81 related articles for article (PubMed ID: 15301741)
1. Enzyme activity analysis of CYP2C18 with exon 5 skipped.
Zhu-Ge J; Yu YN
Acta Pharmacol Sin; 2004 Aug; 25(8):1065-9. PubMed ID: 15301741
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing.
Zhu-Ge J; Yu YN; Qian YL; Li X
World J Gastroenterol; 2002 Oct; 8(5):888-92. PubMed ID: 12378636
[TBL] [Abstract][Full Text] [Related]
3. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
5. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
Tang NH; Wang XQ; Li XJ; Chen YL
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
[TBL] [Abstract][Full Text] [Related]
6. Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue.
Zhuge J; Yu YN
World J Gastroenterol; 2004 Nov; 10(22):3356-60. PubMed ID: 15484318
[TBL] [Abstract][Full Text] [Related]
7. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
Xu KS; Wang HF; Qian W; Wang BH
Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
[TBL] [Abstract][Full Text] [Related]
9. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.
Chang TK; Yu L; Goldstein JA; Waxman DJ
Pharmacogenetics; 1997 Jun; 7(3):211-21. PubMed ID: 9241661
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection.
Li KQ; Li WL; Peng SY; Shi XY; Tang HL; Liu YB
Chin Med J (Engl); 2004 Sep; 117(9):1364-9. PubMed ID: 15377430
[TBL] [Abstract][Full Text] [Related]
11. Defective secretion of albumin encoded by exon-skipped mRNA found in aged analbuminemic rat liver.
Sugiyama K; Sugimura T; Esumi H
Eur J Cell Biol; 1993 Aug; 61(2):239-46. PubMed ID: 8223714
[TBL] [Abstract][Full Text] [Related]
12. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
13. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
[TBL] [Abstract][Full Text] [Related]
14. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line.
Zhuge J; Luo Y; Yu YN
World J Gastroenterol; 2003 Dec; 9(12):2732-6. PubMed ID: 14669323
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
16. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
17. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
18. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
19. [Diclofenac suppresses hepatoma cell proliferation and promotes cyclooxygenase-2 mRNA expression].
Chen NN; Wu SG
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):814-7. PubMed ID: 16793607
[TBL] [Abstract][Full Text] [Related]
20. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells].
Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS
Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]